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Abstract: 
Objective  
To determine the feasibility and short-term efficacy of caregiver-directed 
constraint induced movement therapy to improve upper limb function in 
young children with hemiplegic cerebral palsy.  
Design  
Randomised controlled trial with masked assessment  
Setting  
Community paediatric therapy services  
Subjects  
Preschool children with hemiplegic cerebral palsy  
Interventions  
Caregiver-directed constraint induced movement therapy administered 
using either  24-hour short-arm restraint device (prolonged) or 
intermittent holding restraint during therapy (manual).  
Main measures  
Primary: Assisting Hand Assessment (AHA) at ten weeks. Secondary: 
adverse events, Quality of Upper Extremity Skills Test, Pediatric Quality of 
Life Inventory. Feasibility: recruitment, retention, data completeness, 
adherence.  
Results  
62/81 (72%) of eligible patients in 16 centres were randomised (prolonged 
restraint n=30; manual restraint n=32) with 97% retention at 10 weeks. 
The mean change at ten weeks on the AHA logit-based 0-100 unit was 9.0 
(95% CI: 5.7, 12.4, p<0.001) for prolonged restraint and 5.3 (95% CI: 
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
For Peer Review
1.3, 9.4, p=0.01) for manual restraint with a mean group difference of 3.7 
(95% CI: -1.5, 8.8, p=0.156) (AHA smallest detectable difference=5 
units). No serious related adverse events were reported. There were no 
differences in secondary outcomes. More daily therapy was delivered with 
prolonged restraint (60 versus 30 minutes; p<.001). AHA data were 
complete at baseline and 10 weeks.  
Conclusions  
Caregiver-directed constraint induced movement therapy is feasible and 
associated with improvement in upper limb function at 10 weeks. More 
therapy was delivered with prolonged than with manual restraint, 
warranting further testing of this intervention in a longer term trial.  
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Abstract (245 words) 
Objective 
To determine the feasibility and short-term efficacy of caregiver-directed constraint 
induced movement therapy to improve upper limb function in young children with 
hemiplegic cerebral palsy. 
Design 
Randomised controlled trial with masked assessment 
Setting 
Community paediatric therapy services 
Subjects 
Preschool children with hemiplegic cerebral palsy 
Interventions 
Caregiver-directed constraint induced movement therapy administered using either a 
24-hour short-arm restraint device (prolonged) or intermittent holding restraint during 
therapy (manual).  
Main measures 
Primary: Assisting Hand Assessment (AHA) at ten weeks. Secondary: adverse events, 
Quality of Upper Extremity Skills Test, Pediatric Quality of Life Inventory. Feasibility: 
recruitment, retention, data completeness, adherence. 
Results 
62/81 (72%) of eligible patients in 16 centres were randomised (prolonged restraint 
n=30; manual restraint n=32) with 97% retention at 10 weeks. The mean change at ten 
weeks on the AHA logit-based 0-100 unit was 9.0 (95% CI: 5.7, 12.4, p<0.001) for 
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prolonged restraint and 5.3 (95% CI: 1.3, 9.4, p=0.01) for manual restraint with a mean 
group difference of 3.7 (95% CI: -1.5, 8.8, p=0.156) (AHA smallest detectable 
difference=5 units). No serious related adverse events were reported. There were no 
differences in secondary outcomes. More daily therapy was delivered with prolonged 
restraint (60 versus 30 minutes; p<.001). AHA data were complete at baseline and 10 
weeks. 
Conclusions 
Caregiver-directed constraint induced movement therapy is feasible and was associated 
with improvement in upper limb function at 10 weeks.  More therapy was delivered with 
prolonged restraint and a longer term trial with a no constraint therapy control is 
warranted. 
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Abstract (245 words) 
Objective 
To determine the feasibility and short-term efficacy of caregiver-directed constraint 
induced movement therapy to improve upper limb function in young children with 
hemiplegic cerebral palsy. 
Design 
Randomised controlled trial with masked assessment 
Setting 
Community paediatric therapy services 
Subjects 
Preschool children with hemiplegic cerebral palsy 
Interventions 
Caregiver-directed constraint induced movement therapy administered using either  24-
hour short-arm restraint device (prolonged) or intermittent holding restraint during 
therapy (manual).  
Main measures 
Primary: Assisting Hand Assessment (AHA) at ten weeks. Secondary: adverse events, 
Quality of Upper Extremity Skills Test, Pediatric Quality of Life Inventory. Feasibility: 
recruitment, retention, data completeness, adherence. 
Results 
62/81 (72%) of eligible patients in 16 centres were randomised (prolonged restraint 
n=30; manual restraint n=32) with 97% retention at 10 weeks. The mean change at ten 
weeks on the AHA logit-based 0-100 unit was 9.0 (95% CI: 5.7, 12.4, p<0.001) for 
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prolonged restraint and 5.3 (95% CI: 1.3, 9.4, p=0.01) for manual restraint with a mean 
group difference of 3.7 (95% CI: -1.5, 8.8, p=0.156) (AHA smallest detectable 
difference=5 units). No serious related adverse events were reported. There were no 
differences in secondary outcomes. More daily therapy was delivered with prolonged 
restraint (60 versus 30 minutes; p<.001). AHA data were complete at baseline and 10 
weeks. 
Conclusions 
Caregiver-directed constraint induced movement therapy is feasible and associated with 
improvement in upper limb function at 10 weeks. More therapy was delivered with 
prolonged than with manual restraint, warranting further testing of this intervention in a 
longer term trial. 
 
 
Key words 
Hemiplegic cerebral palsy, constraint induced movement therapy, upper limb 
rehabilitation, therapy, randomised controlled trial 
 
 
 
Page 5 of 45
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
3 
 
Introduction 
Around a third of children with cerebral palsy present with hemiplegic cerebral palsy.1 
Upper limb spasticity, weakness, dystonia2 and sensory deficits3 are commonly seen 
and can lead to poor grasp4 and poor object release.5 Children favour their unaffected 
limb, amplifying the problem,6 and require long term family, healthcare and social 
support.7 
 
Interventions to improve the use of the impaired limb are an important component of a 
rehabilitation programme but high quality evidence is lacking.8,9 Constraint induced 
movement therapy aims to overcome non-use of the affected limb through movement 
restriction of the unaffected upper limb and intense training of the affected upper 
limb.10,11 A Cochrane systematic review12 concluded that it was a promising therapeutic 
approach for children with hemiplegic cerebral palsy. 
 
Studies to date have lacked systematic comparison of the critical variables including: 
type of restraint (full-arm cast to gentle parental holding), duration of restraint (1-24 
hours per day) and intervention duration (one hour therapy per week to seven hours per 
day).13,14 
 
Caregiver-directed rehabilitation is an important component of therapy in the National 
Health Service (NHS) enabling increased dose. A number of studies have explored the 
effect of care-giver directed constraint induced movement therapy15-17. This approach 
has advantages especially in terms of therapy resources and improvement 
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demonstrated  in bimanual function but two of the studies reported high (30%) dropout 
rates16,17 and another stated that although most parents (96%) found it worthwhile many 
(75%) had some difficulty with implementation.15  
 
We explored the short-term efficacy of a novel caregiver-directed prolonged constraint 
induced movement therapy intervention, comparing it with intermittent manual constraint 
induced movement therapy which is sometimes used in current NHS practice. Based on 
clinical experience and parent consultation, the latter was considered unlikely to be 
effective in this clinical context and therefore suitable as a control intervention. The 
interventions were delivered within usual NHS community paediatric therapy services. 
The study also tests the feasibility of multicentre trials in this population and setting. 
 
Methods 
This parallel-group, randomised, controlled trial with blinded assessment was conducted 
in NHS community paediatric therapy services. A favourable opinion was received from 
the South Birmingham Research Ethics Committee (ref: 10/H1207/36). It was 
sponsored by the University of Birmingham and registered with International Standard 
Randomised Controlled Trial Number (58484608). The study was funded by a West 
Midlands Strategic Health Authority Clinical Academic Doctorate Fellowship awarded to 
Pauline Christmas (PC) and the Nancie Finnie Cerebral Palsy Charity. Two centres 
were recruited directly by the investigator and the others after national publicity via 
professional networks. Site physiotherapists or occupational therapists were 
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experienced in treating children with cerebral palsy and received a two-hour face-to-
face training session on the trial protocol. 
 
Eligible children were identified from treatment databases of participating NHS services 
by their therapist. The therapist approached the parents and, if interested, the parent 
and child attended a face-to-face session. The treatment options and treatment 
allocation were discussed and the parent received an information sheet. Support from 
an interpreter was provided if required. Parents had at least 24 hours before giving 
informed consent. 
 
Children with a diagnosis of hemiplegic cerebral palsy irrespective of cognitive 
impairment aged between 18 months and four years were eligible. Exclusion criteria 
were patients presenting with a contra-indication to the intervention such as a skin 
condition that prohibited the use of a persistent immobilisation device, and patients must 
not have received an episode of prolonged constraint induced movement therapy 
lasting two weeks or more in the previous six months. 
 
Following informed consent and the baseline assessment the site therapist telephoned 
the Primary Care Clinical Research and Trials Unit at the University of Birmingham for 
randomisation. The Unit was independent of the research team ensuring concealed 
allocation. A balanced blocked randomisation schedule stratified by centre (nQuery 
Advisor 7.0, Statistical Solutions, USA) generated by a statistician was used. 
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Outcomes were measured at baseline, immediately post intervention at ten weeks and 
at the 24-week follow-up. Baseline and ten-week assessments were conducted at the 
usual therapy location during a face-to-face visit by PC who was blind to patient 
allocation and the site therapist. The 24-week follow-up was conducted through postal 
questionnaires. 
 
The primary outcome measure was bimanual performance of the affected upper limb 
measured using the Assisting Hand Assessment 18,19 assessed at baseline and at the 
ten-week assessment by PC, an accredited assessor. The child took part in a 15 minute 
semi-structured video-recorded play session. This was scored on a 22-item schedule 
divided into general usage (3 items), arm use (4 items), grasp-release (7 items), fine 
motor adjustment (3 items) coordination (2 items) and pace (3 items) using a 4-point 
criterion referenced rating scale (1-4) for each item with higher scores indicating better 
function. Total scores were reported using a logit-based 0-100 unit scale. The smallest 
detectable difference of the Assisting Hand Assessment is 5 logit-0-100 units.20 
 
Secondary outcome measures were: 
• Upper limb quality of movement assessed using the Quality of Upper Extremity 
Skills Test21,22 at baseline and ten weeks to evaluate benefit to the affected upper 
limb and possible harm to the unaffected upper limb through immobilisation. 
• The Paediatric Quality of life Inventory  4.0 Generic Core Scales23 was combined 
with the Paediatric Quality of life Inventory  3.0 Cerebral Palsy  Module24 for 
children aged two years or more was used at baseline, the ten-week and 24-
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week assessment. The Paediatric Quality of life Inventory Infant Scale25 was 
administered for children who were younger than two years.  
• The Birmingham Bimanual Questionnaire  is a trial specific, parent reported 
measure  to assess  pre-requisites for bimanual function and bimanual tasks in 
the affected upper limb. It was included at baseline, the ten and 24-week 
assessment. (See Appendix 1, Figure 2).  
 
Adverse events were recorded by the therapists following weekly contacts with 
caregivers, reported to the trial team and were reviewed clinically by a consultant 
paediatrician. 
 
Feasibility was assessed on: recruitment numbers; recruitment rate from eligible 
families recorded on screening logs; retention; completeness of outcome measure data; 
the child’s cooperation with restraint; and amount of therapy delivered. The amount of 
prescribed therapy delivered and child’s cooperation was recorded by the caregivers in 
a daily diary and through a weekly face-to-face or telephone questionnaire administered 
by the site therapist. The responses were collected on a five point Likert scale. For the 
therapy dose when asked how many of the 60 minutes were completed they could 
respond: “hardly at all” (=1), “less than 30 minutes” (=2), “for 30 minutes” (=3), “nearly 
60 minutes” (=4) and “all 60 minutes” (=5) and for the child’s cooperation the responses 
included: “never” (=1), “seldom” (=2), “about half the time” (=3), “usually” (=4), “always” 
(=5). 
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Safeguards were put in place to maintain blinding of the assessor because families and 
therapists could not be blinded to group allocation26 27. These included: reminder to 
parents not to discuss group allocation in front of the trial assessor; research notes kept 
in a locked filling cabinet; adverse events reported to the trial coordinator rather than the 
principal investigator; data analysis commencing after the trial database was locked; 
reminder on the trial assessor’s mobile phone and email not to disclose group 
allocation. Inadvertent un-blinding was recorded on the trial database. 
 
The caregiver-directed constraint induced movement therapy interventions used either a 
24-hour short-arm device (prolonged) method of restraint applied by the therapist or 
hand-over-hand holding of the unaffected upper limb (manual)28 carried out 
intermittently through the day (Table 1), by the caregiver. Training on the allocated 
restraint for the caregiver was conducted by the site therapist during an initial face-to-
face session with fortnightly face-to-face and weekly telephone contact although 
caregivers could telephone in-between. 
 
In both groups therapy was administered for one hour each day in the child’s usual 
setting by caregivers (parents and pre-school workers) for six weeks (three blocks of 
two weeks) interspersed with two weeks of rest to promote adherence and reduce the 
potential for adverse events. Intervention period timing was flexible to fit with family life 
but was completed within ten weeks.  
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The interventions aimed to promote mass practice of the affected upper limb to improve 
grasp, release, reaching, in-hand manipulation and use as an assisting hand during 
bimanual activity. The practice was embedded in the context of functional tasks or usual 
child-friendly play for a total of one hour, which could be divided to fit with the child’s 
usual routine. To encourage participation, the activity aimed to be enjoyable with 
substantial verbal encouragement and praise. If the therapist found there were no toys 
available a small number of suitable toys were provided. The instructions are outlined in 
Appendix 2.3. The amount of prescribed therapy delivered and the child’s cooperation 
was recorded by the caregivers in a daily diary and through a weekly face-to-face or 
telephone questionnaire administered by the site therapist. 
 
The sample size calculation was based on 90% power in a two sample t-test to 
compare change in outcome from baseline between the groups with α set to 0.05. 
Eliasson and colleagues29 conducted a study of constraint induced movement therapy 
in young children with hemiplegic cerebral palsy using the Assisting Hand Assessment 
as the primary outcome measure. The treatment effect was 1.16 at the end of the 
therapy period (two months) and demonstration of a similar short term effect would 
justify a larger multi-centre trial. Given these assumptions, twenty-three participants in 
each group would detect an effect size of 1.0 following treatment between groups. 
Participant retention was estimated at 70%, which gave a total sample size of 60 
participants. 
 
Page 12 of 45
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10 
 
An intention-to-treat analysis was conducted. A between-group comparison of the 
primary and secondary outcomes and mean change were computed at each time point. 
Interval data were analysed with independent t-tests and categorical data with the chi-
squared test. Within group comparison at baseline and ten-week assessments was 
made using dependent t-tests. Effect sizes were calculated where appropriate. Non-
parametric tests were used where parametric assumptions were not met.  
 
The responses and scores in the daily diaries and weekly questionnaires were analysed 
with descriptive statistics. The median and interquartile ranges were calculated from the 
daily diaries and weekly questionnaires for therapy dose and cooperation of the child 
after the missing responses had been removed. Alpha-level was set at 0.05 for all 
statistical analyses, which were conducted using a statistical software package (SPSS 
version 20, IBM Corporation, Armonk, New York). 
 
Results 
Sixteen community paediatric therapy services across England and Wales recruited 62 
out of 81 eligible participants (76%) between June 2010 and January 2012 (See Flow 
diagram, Figure 1).  Reasons for declining participation were child’s behaviour (n=2), 
child’s independence (n=2), child’s health (n=3), attendance at an educational 
placement (n=2), health care and other commitments (n=2), did not want intervention 
(n=2), did not want to participate in research (n=1). Five parents gave no explanation. 
The first and largest centre set up before further centres were recruited following 
national advertising recruited 19 out of the centre’s 21 eligible patients. The remainder 
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of centres recruited between one and four patients, after inviting between one and 
seven. Reasons for declining participation were child’s behaviour (n=2), child’s 
independence (n=2), child’s health (n=3), attendance at an educational placement 
(n=2), health care and other commitments (n=2), did not want intervention (n=2), did not 
want to participate in research (n=1). Five parents gave no explanation.No patients met 
the exclusion criteria. Data were collected from all participants at all time points except 
from two at the ten-week assessment and three at 24-weeks. Baseline information 
across groups showed some imbalance for age (Table 2). 
Outcome measures were well completed with no missing data for the Assisting Hand 
Assessment. The Quality of Upper Extremity Skills Test was 89% (55/62) complete at 
baseline and 91% (55/60) at ten w eks. The Paediatric Quality of life Inventory in 
combination with the Cerebral Palsy module was returned for 96% (49/51) at baseline 
and 94% (48/51) at the ten and 24- week assessments. The Paediatric Quality of life 
Inventory infant scale was 100% (11/11) complete at all time points. The Birmingham 
Bimanual Questionnaire response was 81% (50/62) at baseline, 97% (60/62) at ten-
weeks and 95% (59/62) at 24-weeks. There was a 94% (58/62) response rate for the 
diaries and 87% (54/62) for the parent questionnaires. The assessor was aware of 
group allocation for only 8% (5/62) of the participants. 
 
The mean change in bimanual performance between groups measured with the 
Assisting Hand Assessment logit-based 0-100 unit from baseline following the ten-week 
intervention was 9.0 (95% CI: 5.7, 12.4, p<.001) units for prolonged restraint and 5.3 
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(95% CI: 1.3, 9.4, p=.01) units for manual restraint with a mean group difference of 3.7 
(95% CI: -1.5, 8.8, p=.156) units (Table 3).  
 
Upper limb function of the upper limbs measured with the Quality of Upper Extremity 
Skills Test at ten weeks was similar to baseline for both groups (see Table 3 for total 
scores and Appendix 1 Table 4 for the Quality of Upper Extremity Skills Test subgroup 
scores). 
 
There was no significant between group differences for children aged two years and 
above at baseline or in change from baseline to the ten or 24-week assessment on the 
Paediatric Quality of life Inventory Generic Core Scale and Paediatric Quality of life 
Inventory Cerebral Palsy Module. Nor were there differences for younger children (less 
than two years) in change from baseline to ten-week assessment or from ten to the 24-
week assessment on the Paediatric Quality of life Inventory Infant Scale. There was a 
significant difference in the mean change from baseline to the 24-week assessment on 
the Paediatric Quality of life Inventory Infant Scale (6.9; 95% CI: 2.8, 11.1; p=0.006) with 
a greater mean deterioration observed in the manual restraint group (-9.4; SD: 3.2) 
compared to the prolonged restraint group (-2.5; SD: 1.6) (Appendix I Tables 5-7 and 9-
11). 
 
There was a statistically significant improvement in motor skills measured on the 
Birmingham Bimanual Questionnaire in the prolonged restraint group compared to the 
manual restraint group at ten weeks, 16.9 (95% CI: 2.9, 30.9, p=.019). This was not 
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sustained at 24 weeks, 1.1 (95% CI: -12.5, 14.6, p=.873). (Appendix 1: Tables 8 and 
12). 
 
Three serious adverse events were reported in the prolonged restraint group (hospital 
admission for flu induced wheeze, accident and emergency attendances for chest 
infection and a total body rash) and one in the manual restraint group (hospital 
admission following a fit): these were considered unrelated to the interventions. Of the 
15 non-serious adverse events, 12 were considered to be related to the prolonged 
restraint including two children who had minor bruising because of a fall and ten with 
small areas of skin abrasions. The three remaining non-serious adverse events in the 
prolonged restraint group were not considered related to the intervention. See Appendix 
1, Table 13. 
 
The median therapy dose reported by parents (data available for 54 out of 62 patients) 
was significantly greater (p<0.001) in the prolonged restraint group (4.2; IQR: 0.9) 
compared to the manual restraint group (3.6, IQR: 1.3). Children (response: 53/62) were 
more cooperative in the prolonged restraint group (4.7, IQR: 1.0) than in the manual 
restraint group (3.0; IQR: 1.7) (p<0.001).  
 
An exploratory regression analysis was carried out with the logit-based 0-100 AHA-unit 
scale at the ten-week assessment as the dependent variable. Group allocation, 
participant age, baseline clinical presentation (measured with QUEST and the AHA), 
amount of therapy delivered and co-operation with the restraint of the delivered 
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intervention were the independent variables in the model:  none made statistically 
significant contributions to the model. 
 
Discussion  
Bimanual performance of children with hemiplegic cerebral palsy after 10 weeks of 
therapy was similar in the two groups of children using different methods of constraint 
induced movement therapy. Both groups improved by more than the minimal detectable 
difference on the Assisting Hand Assessment but the threshold for clinically significant 
improvement on this measure is unclear. Reported adherence was good. Children were 
more cooperative and received a higher therapy dose with prolonged restraint but 
adherence was better than expected in the manual restraint group, reducing the 
difference between the groups . Recruitment in the NHS community setting was 
feasible, although more sites than anticipated were needed as there were fewer eligible 
patients below the age for UK compulsory education than expected. There was 
excellent follow-up of more than 95% at ten and 24 weeks with satisfactory data 
completion. Broad inclusion criteria enhanced generalisability. 
 
The improvement in bimanual performance at ten weeks irrespective of the type of 
restraint applied is consistent with a previous Cochrane systematic review12 and further 
studies13,14. Previous meta-analysis in neurological rehabilitation have emphasised the 
importance of dose30,31 and in our study the care-giver directed prolonged restraint 
method was associated with a greater dose than manual restraint. As with other studies 
using a prolonged restraint approach, there was minimal reporting of adverse 
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events.32,33,34  
In contrast to previous studies of care-giver directed constraint therapy16,17, there was 
excellent adherence and follow-up rates with both intermittent manual holding and 
prolonged restraint with a short-arm device left in situ.   A novel aspect of the prolonged 
restraint protocol was that caregivers administered only the mass practice with 
application and removal of the restraint being carried out by the therapist. This may 
have reduced the burden on parents, increasing acceptability and improving adherence. 
As prolonged restraint was associated with delivery of more therapy and is acceptable 
to parents, it is our preferred method in further effectiveness research. 
The trial has some limitations. Only caregiver reported  assessment of adherence to 
treatment was possible. Although masking was largely successful, the assessor was 
aware of group allocation for 8% of the participants at the ten-week assessment. 
Resource constraints meant the trial was powered to evaluate 10 week not longer term 
outcomes. 
 
We have shown in multiple centres that constraint induced movement therapy can be 
successfully administered in NHS community paediatric therapy services with caregiver-
directed therapy. Our study suggests prolonged restraint results in more intense therapy 
and can be used safely. Children in the prolonged restraint group had more risk of skin 
abrasions: this risk was managed by using a short easily removable padded device that 
allowed some protective extension. Parents were advised to give more supervision on 
the stairs and in situations where the child’s balance was challenged. All adverse events 
resolved quickly. Minor bruising from falls and skin abrasions are common in this age 
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group and may have occurred in the intermittent holding group but not have been 
reported. There was no difference in function of the immobilized limb at ten weeks 
suggesting no harm from restraint. 
This is one of the largest randomised controlled trials conducted to investigate 
constraint induced movement therapy in young children with hemiplegic cerebral palsy: 
we are not aware of other multicentre pragmatic community based randomised 
controlled trials. An adequately powered trial with longer term, blinded outcome 
assessment is required. As caregiver-directed constraint induced movement therapy 
delivered more practice, may lead to a better outcome than manual restraint, and is 
acceptable to parents and patients, this method of restraint is our preferred intervention.  
A control intervention with no constraint therapy (for example, waiting list, attention 
control, usual therapy) would increase the statistical power of the study by increasing 
the contrast between the expected group outcomes.  Such a trial is needed to evaluate 
the long term clinical and cost effectiveness of community based constraint induced 
movement therapy.  
 
Clinical messages 
• Constraint induced movement therapy for children with hemiplegic cerebral palsy 
can be successfully delivered by caregivers. 
• Prolonged restraint delivered more intense upper limb therapy than manual 
restraint but was not more effective. 
• A randomised control trial of prolonged restraint versus no constraint therapy is 
warranted and feasible. 
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Table 1.Description of methods of restraint 
          
      Prolonged restraint 
 
      Manual restraint 
• 24-hour short-arm restraint 
applied by therapist, in place 
throughout the two-week 
intervention blocks 
• therapy conducted little and often 
by caregiver (one hour per day) 
• custom-made semi-rigid cast (3M 
soft cast) or wrist splint extending 
from the metacarpal heads to 
above the wrist, crepe bandage 
enclosing the fingers and thumb  
• well-padded to minimise skin 
abrasions, allows some protective 
use  
• review if non-acceptance by child 
persists for three to four days 
• caregiver could easily remove if 
needed 
• caregivers were advised extra 
supervision be provided and 
activity challenging balance 
limited 
• See Appendix 2.1 for the 
instructions to the site therapist.  
• intermittent holding restraint 
conducted little and often by 
caregiver during therapy (one hour 
per day) 
• holding was hand-over-hand, 
never forceful 
• See Appendix 2.2 for instructions 
to caregivers  
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Table 2. Baseline characteristics across group. 
AHA: Assisting Hand Assessment; QUEST: Quality of Upper Extremity Skills Test; PedsQL: 
Paediatric Quality of life Inventory; CP Cerebral palsy. 
 
 Prolonged restraint 
(n=30) 
Manual restraint 
(n=32) 
p-value 
 n(%) n(%) p-
value(χ2) 
Male 19(63) 13(41) .125 
White British 
 
21(66) 16(50) .284 
Attends nursery  12(40) 13(41) .100 
 
 
Mean(±SD)               Mean(±SD) 
 
 
p-value 
(t test) 
Age(months)  31.5(12.2) 29.0(11.8) .427 
Deprivation scores 1 (most 
deprived area) to 32,844 (least 
deprived area). 
 
9975.5(8357.3) 7941.3(7557.6) .326 
AHA 43.8(22.6) 44.6(29.0) .894 
QUEST (Summary score)  70.8(15.0) 71.5(11.1) .843 
PedsQL Generic Core Scale 
(Summary score; ≥two years n=51) 
 
68.4(12.2) 68.6(11.6) .966 
PedsQL CP Module  
(≥two years n=51) 
Daily Activity                              
Movement & Balance 
Pain & Hurt 
Fatigue 
Eating Activities 
 
 
14.8(16.3) 
55.6(23.7) 
82.5(16.8 
77.0(18.8) 
73.2(22.6) 
 
 
26.9(24.5) 
61.7(25.6) 
75.0(25.4) 
75.8(18.5) 
73.4(20.5) 
 
 
.047 
.393 
.227 
.820 
.976 
 
PedsQL Infant Scale  
(Summary score;< two years n=11) 
 
 
83.1(12.6) 
 
85.1(13.1) 
 
.810 
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Table 3. Mean difference across groups of the change in the Assisting Hand Assessment (primary outcome) and the Quality of 
Upper Extremity Skills Test from baseline to the ten-week assessment. 
 
 
Assisting Hand Assessment AHA logit-based 0-100 unit 
Group Baseline 
mean (±SD) 
95% CI 
 
Change 
mean (±SD) 
95%CI Mean difference 
(95% CI) 
p-value 
t-test 
PR (n=29) 43.8 (22.6) 35.4,52.3 9.0 (8.8) 5.7, 12.4 3.7 
(-1.5, 8.8) 
.156 
MR (n=31) 44.6 (29.0) 34.3, 55.1 5.3 (10.8) 1.3, 9.4 
 
Quality of Upper Extremity Skills Test (total scores %) 
PR (n=29) 70.8 (15.0) 65.3, 76.4 -1.5 (8.9) -4.9, 1.9  
.08 (-4.6,4.5) 
 
.970 
MR (n=31) 71.5 (11.1) 67.5, 75.5 -1.6 (7.8) -4.5, 1.3 
 
PR: prolonged restraint; MR:  manual restraint; CI: confidence interval  
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Figure 1. CONSORT diagram of participant flow through trial. 
Allocated to manual restraint 
delivered during therapy by care 
giver (n=32) 
Ten-week outcome assessment  
Primary outcome (AHA) 
(n=31) 
 
Moved area missing ten-week 
assessment but completed 24-week 
assessment (n=1) 
Allocated to prolonged restraint applied by 
therapist and managed by caregiver(n=30)  
 
Dropped out (parental decision) before 
completing intervention (n=1) 
Randomisation (n=62) 
 Assessed for eligibility (n=81) 
Declined to participate  
(n=19) 
Follow-up 24-week postal assessment 
(n=27) 
Follow-up not obtained (n=1) 
Moved area (n=1) 
not traceable (n=1) 
Follow-up 24-week postal 
assessment 
(n=32) 
Ten-week outcome assessment  
Primary outcome (AHA) 
(n=29) 
 
 
Three (two week) blocks of caregiver delivered therapy for 
one hour each day completed in ten weeks 
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Appendix 1 
Table 4: Mean difference across groups of the change in the quality of upper extremity skills test from baseline to the ten-week 
assessment on total and subgroup scores (%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
 
 Baseline 
Mean 
(±SD) 
95% 
CI 
Lower 
95% 
CI 
Upper 
n  ten-weeks 
Mean(±SD) 
Mean 
(±SD) 
change  
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference in mean 
change 
(95% CI) 
p-
value 
t-test 
Total scores 
 
PR 70.8(15.0) 65.3 76.4 29 71.6(11.7) -1.5(8.9) -4.9 1.9 .08(95% CI-4.6,4.5) .970 
MR 71.5(11.1) 67.5 75.5 31 73.3(11.7) 
 
-1.6(7.8) -4.5 1.3 
Dissociated movement 
PR 75.2(11.5) 70.9 79.5 29 76.0(9.7) 1.6(8.3) -1.5 4.6 -.63(95% CI-5.2,4.0) .784 
MR 74.6(12.5) 70.1 79.1 31 77.0(10.3) 2.2 (9.5) -1.2 5.7 
Grasp 
PR 60.3(13.9) 55 65.5 29 62.0(14.7) 2.9(10.3) -1.1 6.8 3.3(95% CI-2.1, 8.7) .227 
MR 65.9(17.4) 59.6 72.1 31 65.3(17.6) -0.5(10.7) -4.4 3.5 
Weight-bearing 
PR 74.0(24.7) 65 83.3 28 78.2(13.7) 2.1(18.3) -4.5 9.2 2.2 (95% CI-5.2, 9.7) .551 
MR 74.5(2.5) 70 79 31 74.4(13.5) -0.1(9.15) -3.5 3.2 
Protective extension 
PR 76.7(18.7) 69.0 84.4 24 73.4(16.8) -.43 -9.8 5.64 1.6(95%CI:-9.0,12.2) .758 
MR 71.5(15.7) 65.6 77.3 28 70.5(15.2) -2.0(19.9) -8.0 7.1 
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Table 5: Mean group difference of change in summary and dimension scores of the Paediatric Quality of life Inventory 4.0 Generic 
Core Scale from  
baseline to the ten-week assessment. 
 
 Baseline 
mean 
(±SD) 
95% 
CI 
Lower 
95% 
CI 
Upper 
n  Mean 
(±SD) 
change  
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference in mean 
change 
(95% CI) 
p-value 
Total 
 
PR 68.4(12.2) 62.5 74.3 15 3.9(11.3) -2.3 10.2 2.73(-7.09, 12. 6) .574 
MR 68.6(11.6) 62.6 74.6 17 1.2(15.3) -6.6  9.0 
psychosocial summary 
 
PR 73.3(11.9) 67.6 79.0 15 2.9(14.2) -5.0 10.7 4.79(-7.4, 16.9) .428 
MR 74.4(11.5) 68.5 80.4 17 -1.9(18) -11.6 7.7 
physical summary 
 
PR 53.6(20.3) 43.4 63.8 22 4.4(14.6) -2 10.9 -5.14(-16.4, 6.1) .361 
MR 49.9(19.1) 40.7 61.2 23 9.5(21.9) .04 19.0 
emotional functioning 
 
PR 65.8(20.0) 56.2 75.4 22 1.9(18.7) -6.3 10.3 -3.44(-14.4, 7.5) .531 
MR 68.2(16.4) 59.7 76.7 23 5.4(17.8) -2.3 13.1 
social functioning 
 
PR 86.8(12.7) 80.0 93.6 22 -10.5(18.0) -18.0 -2.5 -4.47(-17.8, 8.8) .500 
MR 83.5(11.0) 77.5 89.5 23 -6.0(25.4) -17.0 5.0 
nursery functioning 
 
PR 67.3(17.8) 58.7 75.9 15 11.3(19) .8 22.0 14.33(-1.4, 30.1) .073 
MR 71.6(16.4) 63.1 80.o 17 -2.9(24) -15.2 9.4 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
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Table 6: Mean difference across groups of the change in the dimension scores of the Paediatric Quality of life Inventory Cerebral 
Palsy Module from baseline to the ten-week assessment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group Baseline 
Mean 
(±SD) 
95% 
CI 
Lower 
95% 
CI 
Upper 
n Mean  
(±SD) 
Change 
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference in mean 
change 
(95% CI) 
p-value 
Daily activity 
PR 14.8(16.3) 8.0 21.5 20 9.8(22.8) -0.9 20.4 1.16 (-14.8, 17.1) .883 
MR 26.9(24.5) 16.5 37.2 23 8.6(28.0) -3.6 20.7 
 
Movement and balance 
PR 55.6(23.7) 45.8 65.4 22 8.0(23.0) -2.3 18.3 10.05(-5.3, 25.4) .193 
MR 61.7(25.6) 50.9 72.5 22 -2.1(27.0) -14.1  9.9 
 
Pain and hurt 
PR 82.5(16.8) 75.6 89.4 20 0.6(19.2) -8.4 9.6 -5.35(-16.0, 5.3) .318 
MR 75(25.4) 64.8 85.7 23 6.0(15.5) -.7.0 12.6 
 
Fatigue 
PR 77.0(18.8) 69.2 84.8 21 -8.6(25.4) -20.2 2.9 -7.54(-21.7, 6.6) .287 
MR 75.8(18.5) 68.0 83.6 23 -1.0(20.9) -10.1 8.0 
 
Eating activities 
PR 73.3(22.6) 64.0 82.6 22 2.8(20.7) -6.0 12.0 -2.87(-15.20, 9.5) .642 
MR 73.4(20.5) 64.8 82.1 23 5.7(20.3) -3.0 14.5 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
 
Page 31 of 45
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
29 
 
Table 7: Mean difference across groups of the change in the summary and dimension scores of the Peds-QL Infant Scale from  
baseline to the ten-week assessment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
 
 
 Baseline  
mean 
(±SD) 
95% 
CI 
Lower 
95% 
CI 
Upper 
n  Mean 
(±SD) 
 change  
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference in mean 
change 
(95% CI) 
p-
value 
Summary 
PR 83.1(12.6) 63.1 103.1 4  0.17(42.0) -6.6 6.9 11.6(-26.4, 3.2) .145 
MR 85.1(13.1) 73.0 97.3 7 -10.0(12.0) -21.4 1.2 
Psychosocial summary 
PR 79.5(18.4) 50.3 108.7 4  1.1(3.8) -5.0 7.2 11.56(-30.2, 7.0) .193 
MR 85.2(12.7) 73.4 96.9 7 -10.5(16.0) -25.1 4.1 
Physical summary 
PR 83.9(4.8) 76.1 91.5 4  3.4(8.2) -9.7 16.6 8.51(-20.9, 3.9) .155 
MR 80.6(16.5) 65.3 95.9 7 -5.0(9.0) -13.41 3.2 
Physical functioning 
PR 78.5(9.2) 63.9 93.0 4 3.1(16.2) -22.7 28.8 12.16(-36.9, 12.6) .295 
MR 77.4(21) 58.1 96.6 7 -9.1(18.0) -25.7 7.6 
Physical symptoms 
PR 98.6(11.6) 80.0 117.2 4 -5.5(11.4) -23.7 12.7 4.51(-7.1, 16.2) .404 
MR 92.9(20.4) 74.0 111.8 7 -10.0(6.0) -15.6 -4.4 
Emotional functioning 
PR 72.9(24.9) 33.;3 112.5 4 -1.9(7.8) -14.4 10.45 10.01(-33.0, 12.3) .329 
MR 84.0(9.6) 75.2 93.0 7 -12.3(18.8) -29.7 5.0 
Social functioning 
PR 93.8(7.5) 81.8 105.7 4 -1.3(6.3) -11.26 8.8 -2.32(-18.0, 13.4) .746 
MR 96.4(9.4) 87.7 105.2 7 3.6(12.8) -15.4 8.3 
Cognitive functioning 
PR 71.9(25.6) 31.2 112.6 4 6.5(7.9) -6.0 19.1 22.02(-44.5, .5) .054 
MR 75.0(25.0) 51.9 98.1 7 -15.5(18.6) -32.7 1.7 
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Table 8: Mean difference across groups of the change in the Birmingham Bimanual Questionnaire from baseline to the ten-week 
assessment. 
 
 
 
 
 
 
 
 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval; * statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Baseline 
means 
(±SD) 
95%CI 
Lower 
95% CI  
Upper 
n  
 
Mean  
(±SD) 
change 
Difference in mean 
change 
(95% CI) 
p-value 
PR 73.8(16.1) 65.5 82.3 23 20.9(25.9) 16.91(2.9, 30.9) .019* 
MR 68.6(22.6) 59.5 77.25 27 4.0(23.4) 
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Table 9: Mean difference across groups of the change in the dimension and summary scores of the Paediatric Quality of life 
Inventory 4.0 Generic Core Scale between baseline and 24-week assessment and ten and 24-week assessment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
 
 
Baseline and 24- week assessment 
 
Ten and 24- week assessment 
   N Mean (SD) 
Change 
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference  
in mean change 
(95% CI) 
p-value        n Mean (±SD) 
Change 
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference  
in mean 
Change (95% CI) 
p-
value 
Summary  
PR 16 -6.0(17.3) -15.5 3.0 -1.72(-12.8, 9.3,) .754  15 -11.2(15.6) -20.0 -2.5 -4.48(-15.2, 6.2,) .400 
MR 16 -4.5(13.0) -11.4 2.4 17 -6.7(14.0) -14.0 0.5 
Psychosocial summary  
PR 16 -6.0(19.1) -17 3.3 -1.90(-14.4, 10.6,) .758  15 -9.4(16.3) -18.4 -0.3 -5.15(-16.8, 6.5,) .372 
MR 16 -5.0(15.0) -13 3.0 17 -4.2(15.7) -12.3 3.9 
Physical functioning  
PR 21 -6.5(19.2) -15.3 2.3 -.35(-12.2, 11.6,) .954  19 -13.4(20.0) -23.0 -3.7 3.02(-9.3, 15.3) .622 
MR 24 -6.2(20.2) -14.7 2.4 24 -16.3(19.3) -24.6 -8.1 
Emotional functioning  
PR 21 1.9(20.6) -7.5 11.3 1.69(-8.6, 12.0,) .742  19 -0.46(20.0) -10.1 9.2 6.20(-5.4, 17.8) .286 
MR 24 0.2(13.5) -5.5 5.9 24 -6.7(17.5) -14.0 0.7 
Social functioning  
PR 21 -19.8(24.5) -31.0 -8.7 -1.58(-15.4, 2.3) .818  19 -8.9(15.3) -16.3 -1.6 1.52(-9.1, 12.1) .744 
MR 24 -18.2(21.5) -27.3 -9.0 24 -10.5(19.1) -18.6 -2.4 
Nursery functioning  
PR 16 -8.6(24.0) -21.4 4.1 -7.03(-23.4, .3,4) .386  15 -13.9(23.0) -27.0 -.87 -14.37(-30.2, 1.5) .074 
MR 16 -1.6(21.1) -12.8 9.7 17 0.5(20.5) -10.0 11.0 
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Table 10: Mean difference across groups of the change in the dimension scores of the Paediatric Quality of life Inventory 3.0 
Cerebral Palsy module between baseline and 24-week assessment and ten-week and 24-week assessment. 
 
Baseline and 24–week assessment  
 
Ten and 24-week assessment 
 n Mean  
(±SD) 
Change 
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference  
in mean change 
(95% CI) 
p-
value 
 
 
n Mean 
(±SD) 
Change 
95% 
CI 
Lower 
95% 
CI 
Upper 
Difference  
in mean change 
(95% CI) 
p-
value 
Daily activities 
 
 
 
PR 22 5.5(16.7) -1.9 12.9 -2.15 (-15.6, 1.3) .748  18 -2.5 (23.0) -14.0 9.0 -2.02 (-16.7, 12.7) .781 
MR 23 7.6(26.6) -3.9 19.1 23 -0.5 (23.1) -10.5 9.5 
Movement and balance 
 
 
 
PR 22 -2.0(20.6) -11.1 7.0 4.91(-8.8, 17.9) .449  20 -10.3(23.5) -21.2 0.7 -5.76(-20.9, 9.4) .448 
MR 23 -6.9(22.3) -16.6 2.7 22 -4.5 (25.0) -15.7 6.7 
Pain and hurt 
 
 
 
PR 22 -5.7(23.9) -16.3 4.9 -7.86(-21.6, 5.9) .225  18 -4.9(21.0) -15.3 5.6 -2.42(-13.7, 8.9) .670 
MR 23 2.2(21.9) -7.2 11.6 23 -2.4(15.0) -9.0 4.0 
Fatigue 
 
 
 
PR 22 -6.8(19.7) -15.5 1.9 .79(-11.6, 13.2) .898 
 
 
 
19 -2.3(22.0) -12.7 8.0 2.86(-11.1, 16.8) .691 
MR 23 -7.6(21.6) -16.9 1.7 23 -5.2(23.0) -15.0 4.7 
Eating activities 
 
 
 
PR 22 0.6(22.2) -9.3 10.4 7.27(-5.6, 20.2) .261  20 -3.1(20.6) -12.7 6.5 8.19(-4.5, 20.9) .198 
MR 23 -6.7(20.6) -15.6 2.2 23 -11.3(20.5) -20.2 -2.5 
             
PR: prolonged restraint; MR: manual restraint; CI: confidence interval  
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Table 11: Mean difference across groups of the change in the summary and dimension scores of the Paediatric Quality of life 
Inventory Infant Scale between baseline and 24-week assessment and ten-week and 24-week assessment. 
 
Baseline and 24–week assessment 
 
 
 
Ten and 24-week assessment 
 n Mean (±SD) 
change  
baseline  
to 24-weeks 
95% 
CI 
lower 
95% 
CI 
upper 
Difference in  
mean  
change  
(95% CI) 
p-
value 
 
 
n 
 
Mean (±SD) 
change  
ten to 
24-weeks 
95% 
CI  
lower 
95% 
CI 
upper 
Difference  
in mean  
change 
(95%CI) 
 
p-
value 
Summary  
PR 4 -2.5(1.6) -5.0  0.12 6.94 (2.76, 11.1) .006*  4 -2.7(3.7) -8.6 3.3 -6.23(-21.4, 8.9,) .383 
MR 5 -9.4(3.2) -13.4 -5.5  5 3.6(12.2) -11.6 18.8 
Psychosocial summary   
PR 4 1.5(2.9) -3.1  6.2 9.73(4.6, 14.9) .003*  4 0.4(3.4) -5.0 5.8 -4.89(-22.9, 13.1) .541 
MR 5 -8.2(3.5) -12.5 -3.9 5 5.3(14.7) -13.0 23.6 
Physical summary   
PR 4 -3.8(7.5) -15.8 8.2 2.76 (-9.4, 15.3) .618  4 -7.2(5.4) -16.0 1.5 -8.25(-20.8, 4.3) .164 
MR 5 -6.6(8.1) -16.7 3.5 5 1.0(9.3) -10.6 12.6 
Physical functioning   
PR 4 -8.9(21.2) -42.6 24.8 2.46(-30.2, 35.1) .864  4 -12.0 (6.0) -21.4 -2.6 -15.01(-35.5, 5.4) .127 
MR 5 -11.4(20.1) -36.7 13.6 5 3.0 (16.3) -17.2 23.3 
Physical symptoms   
PR 4 -8(9.9) -23.7 7.7 3.07(-10.8, 16.9) .616  4 -2.5 (10.6) -19.4 14.4 -1.50(-15.0, 12.0) .800 
MR 5 -11(7.7) -20.7 -1.5    5 -1.0 (6.5) -9.0 7.0   
Emotional functioning   
PR 4 2.6(5.7) -6.5 11.6 15.66(5.5, 25.9) .009*  4 4.5 (9.7) -10.9 28.5 2.87(-19.9, 25.6) .774 
MR 5 -13.1(7.0) -21.8 -4.4 5 1.6 (17.0) -19.5 22.8 
Social functioning   
PR 4 -2.5(5.0) -10.5 5.5 -1.50(-7.3, 4.3) .563  4 -1.3 (2.5) -5.2 2.7 -8.25 (-23.5, 7.0) .242 
MR 5 -1.0(2.2) -3.7 1.8 5 7.0(12.5) -7.0 22.6 
Cognitive functioning   
PR 4 4.6 (5.7) 4.6 13.6 15.01(-2.4, 32.5) .081  4 -2.0 (4.7) -9.6 5.5 -9.30(-30.7, 12.1) .342 
MR 5 -10.6(13.7) -27.5 -3.9 5 7.2 (17.5) -14.5 28.9 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval * statistically significant. 
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Table 12: Mean difference across groups of the change in the BBMQ from baseline to 24-week assessment and from ten-week to 
the 24-week assessment. 
 
PR: prolonged restraint; MR: manual restraint; CI: confidence interval * statistically significant. 
Baseline and 24-week assessment  Ten and 24-week assessment 
 
 Baseline 
mean (SD) 
n Mean (±SD) 
Change 
Difference 
 in  
mean change 
95% CI) 
p-
value 
 N Mean (±SD) 
change 
 
Difference 
 in  
mean change 
(95% CI) 
p-value 
PR 73.8 
(16.1) 
 
21 3.1(25.1) 1.1(-12.5, 14.6) .873  27 -13.6(23.2) -13.5(-24.9, -2.1) .021* 
MR 68.6 
(22.6) 
27 2.0(21.4) 32 -.13.0(20.4) 
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Table13: Adverse events   
Serious 
Group 
Related to the 
intervention 
Description  
Prolonged 
Restraint 
Unrelated 
Admitted to hospital due to a flu induced wheeze  
 Unrelated Taken to A/E due to chest infection  
 Unrelated Taken to A/E because of a total body rash  
Manual 
Restraint  
Unrelated 
Admitted to hospital following a fit 
Not serious 
 
Prolonged 
Restraint 
Related Bump to the head from a fall  
 Related Bumped head which resulted in a little bruise  
 Related Graze on arm from wrist splint  
 Related Graze and slight bruising on hand  
 Related Rubbing plus moist, smelly arm 
 Related Localised eczema flare-up  
 Related Redness between fingers  
 Related Redness around the thumb  
 Related Redness around the thumb 
 Related Redness around the thumb 
 Related Redness and small area of broken skin on the hand  
 Related Redness and sore, cracked skin on the hand  
 Unrelated Item fell onto participant causing bruising  
 Unrelated Hip pain, 
 Unrelated Raised temperature and rash 
 A/E: accident and emergency department.  
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 Table 14: List of therapists 
Therapist Trust 
Christel Corbett, Jacqueline Parker, 
Marilyn Poole, Katie Roberts. 
NHS South Birmingham Primary Care Trust 
Alison Keeling-Smith, Shabnam 
Moledina. 
NHS Heart of England 
Louise Kelleher, Helen Wilson. Dudley Community Services 
Yvonne Parker. South Staffordshire Primary Care Trust 
Patricia Escott, Claire Parker. Wolverhampton City Primary Care Trust 
Petrina March, Una Peplow, Radella 
Manners, Michele Toorish. 
Sandwell Primary Community Trust 
Ginny Humphreys, Sally Bunney, 
Robert Shaw, Carolyn Allbrook, Louise 
Jennings, Jane Butler. 
NHS Devon 
Sara Butler, Margaret Hotze. Walsall Community Health NHS 
Ella Kajumba, Rose Cormac-Loyd. Lewisham Healthcare NHS Trust 
Phillip Harness, Jacqueline Gordon.  NHS City and Hackney 
Natalie Hayes. NHS Bromley 
Joanna Saunders, Barbara Marsland NHS Telford and Wrekin 
Helen Burchnall. NHS Leicestershire 
Ann Oultram, Louise Monaghan, 
Lorraine Isherwood. 
Alder Hey Children’s Foundation NHS 
Foundation Trust 
Cath Barton, Rebecca Randell. Powys Teaching Health Board 
Kezia Pugh, Janet Rose. NHS Herefordshire 
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We would like to know the difficulties your child has with their affected arm and hand. That is the arm/hand that they do not 
use so well. Please tell us how difficult each one of the items below has been for your child during the past ONE month by 
circling 0-4: There is no right or wrong answer. If you do not understand a question, please ask for help. 
 
 Never Almost  
never 
Some 
times 
Often Almost  
always 
Using their affected arm and hand to keep objects still to play with.  0 1 2 3 4 
Using the affected arm and hand for big movements that use the whole 
arm e.g. reaching, waving or leaning on it.  
0 1 2 3 4 
Grasping an object with their affected hand  0 1 2 3 4 
Releasing an object with their affected hand.  0 1 2 3 4 
Moving the fingers of the affected hand  0 1 2 3 4 
Using both hands together  0 1 2 3 4 
Figure 2: Birmingham Bimanual Questionnaire  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Appendix 2 
2.1. Prolonged restraint 
Application  
Application of a flexible short arm cast from the metacarpal heads to above the wrist 
with the wrist joint positioned in neutral/resting position 
Materials: 
• One/two rolls of 3M soft cast (2.5cm/5cm) 
• 3M Synthetic (2.5cm) stockinette 5com longer than the device 
• One/two rolls 3M synthetic (5cm) cast padding 
• One roll crepe bandage 
• Tape to secure crepe bandage 
Setting 
The prolonged restraint should be applied where possible in a clinic situation however, 
with care it is possible to do this at the child’s home. 
Removal of the cast 
Unwind the crepe bandage and remove. Then remove the cast by finding the end of the 
soft cast and unwind. The stockinette can be then removed. The cast should be 
removed by unwinding, not cutting off. Give an explanation and demonstration on 
removing the prolonged restraint at the first session to the parent. 
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2.2. Manual Restraint 
 
Instruction sheet for parents and nursery workers 
• Your child’s unaffected hand is held gently during an activity to encourage them 
to use their affected hand. 
• You may place your hand on top of your child’s hand if they are playing at a 
table. 
• Between any activities, the hand is not held 
• If they are playing on the floor you may choose to hold your child’s hand or place 
your hand over your child’s hand on the floor. 
• This should be done on a little and often basis and you should aim to get your 
child playing at the same time.  
• At no time is any force applied. If your child objects and starts to get upset, then 
you should stop. 
• This should only be carried out by you and your therapist will teach you how to 
do it.  
• It may be that your therapist identifies another person that would be appropriate 
to do it as well. This could be a nursery worker. With your agreement, the 
therapist will train them on how to do this and they may carry this out when your 
child attends nursery. 
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2.3. Intensive unstructured practice 
Instruction sheet for parents and nursery workers 
This therapy involves getting active use of the affected hand for about 60 minutes 
every  
day but not all at the same time.  
• The affected hand is encouraged to actively move by playing with a toy or 
doing an activity like finger feeding or helping to dress we do not want you to 
move their hand for them. 
• Your therapist will help by giving ideas about what are suitable toys. We want 
this to be as enjoyable as possible. 
• Successful play = easy toys that your child can use                                                                                                                             
                                                                                                                           
 
Make it fun and enjoyable so he/she wants to repeat the activity 
or keep on playing. Give them lots of encouragement 
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported on 
page No 
Title and abstract 
 1a Identification as a randomised trial in the title √ 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for 
abstracts) 
√ 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale √ 
2b Specific objectives or hypotheses √ 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio Page 4 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons  
Participants 4a Eligibility criteria for participants Page 5 
4b Settings and locations where the data were collected Page 5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when 
they were actually administered 
Page 8,9 & 20 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and 
when they were assessed 
Page 5,6 &7 
6b Any changes to trial outcomes after the trial commenced, with reasons  
Sample size 7a How sample size was determined Page 9 
7b When applicable, explanation of any interim analyses and stopping guidelines  
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence Page 5 
8b Type of randomisation; details of any restriction (such as blocking and block size) Page 5 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered 
containers), describing any steps taken to conceal the sequence until interventions were assigned 
Page 5 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned 
participants to interventions 
Page 5 
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Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, 
those assessing outcomes) and how 
Page 5&7 
11b If relevant, description of the similarity of interventions  
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes Page 9&10 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses  
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended 
treatment, and were analysed for the primary outcome 
Page 10& 
Consort 
diagram p23 
13b For each group, losses and exclusions after randomisation, together with reasons Consort 
diagram p23  
Recruitment 14a Dates defining the periods of recruitment and follow-up Page 10 
14b Why the trial ended or was stopped  
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 2 p21 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the 
analysis was by original assigned groups 
Consort 
diagram p23 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and 
its precision (such as 95% confidence interval) 
Table 3 p 21 
&Appendix 1. 
Table 4-12 p 
24-32 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended  
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, 
distinguishing pre-specified from exploratory 
 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) Page 12& 
Appendix 1. 
Table 13 p33 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of 
analyses 
Page 13/14 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings Page 13 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant 
evidence 
Page 14/15 
Other information 
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Registration 23 Registration number and name of trial registry Page 4 
Protocol 24 Where the full trial protocol can be accessed, if available Page 4 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Page 4,15,16 
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